Avi Katz
University of Minnesota
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Avi Katz.
Kidney International | 2010
Giulio Genovese; Stephen Tonna; Andrea L. Uscinski Knob; Gerald B. Appel; Avi Katz; Andrea J. Bernhardy; Alexander Needham; Ross Lazarus; Martin R. Pollak
Genetic variation at the MYH9 locus is linked to the high incidence of focal segmental glomerulosclerosis (FSGS) and non-diabetic end-stage renal disease among African Americans. To further define risk alleles with FSGS we performed a genome-wide association analysis using more than one million single-nucleotide polymorphisms in 56 African-American and 61 European-American patients with biopsy-confirmed FSGS. Results were compared to 1641 European Americans and 1800 African Americans as unselected controls. While no association was observed in the cohort of European Americans, the case-control comparison of African Americans found variants within a 60 kb region of chromosome 22 containing part of the APOL1 and MYH9 genes associated with increased risk of FSGS. This region spans different linkage disequilibrium blocks, and variants associating with disease within this region are in linkage disequilibrium with variants which have shown signals of natural selection. APOL1 is a strong candidate for a gene that has undergone recent natural selection and is known to be involved in the infection by Trypanosoma brucei, a parasite common in Africa that has recently adapted to infect human hosts. Further studies will be required to establish which variants are causally related to kidney disease, what mutations caused the selective sweep, and to ultimately determine if these are the same.
The Journal of Pediatrics | 1996
A. Klar; H. Hurvitz; Y. Berkun; M. Nadjari; G. Blinder; T. Israeli; A. Halamish; Avi Katz; G. Shazberg; D. Branski
We report 13 patients with 16 episodes of acute lobar nephronia diagnosed in a prospective study that was conducted among 210 hospitalized children with urinary tract infection. In 30 episodes of urinary tract infection, a hypoechogenic or hyperechogenic lesion was found. Twenty patients underwent computed tomography, and in 16 of them acute lobar nephronia was diagnosed. Evolution to renal abscess occurred in 25%. Prolonged intravenous antibiotic treatment was sufficient in all cases.
The Journal of Pediatrics | 1990
Avi Katz; Clifford E. Kashtan; Leonard J. Greenberg; Ralph S. Shapiro; Thomas E. Nevins; Youngki Kim
7. Borkowsky W, Krasinski K, Paul D~ et al. Human immunodeficiency virus infections in infants negative for anti-H1V by enzyme-linked immunoassay. Lancet 1987;1:1168-71. 8. Consortium for Retrovirus Serology Standardization. Serologic diagnosis of human immunodeficiency virus infection by Western blot testing. JAMA 1988;260:674-8. 9. Centers for Disease Control. Classification system for human immunodeficiency virus (HIV) infection in children under 13 years of age. MMWR 1987;36:91-6. l 0. Johnson J, Davis E, Sbinaberry R, Nair P. Serologic responses to HIV infection in infants. Presented at the Fifth International Conference on AIDS, Montreal, Quebec, Canada, June 4-9, 1989. 11. Martin K, Katz B, Miller G. AIDS and antibodies to human immunodeficiency virus in children and their families. J Infect Dis 1987;155:54-9. 12. Epstein L, Boucher C, Morrison S, et al. Persistent human immunodeficiency virus type 1 antigenemia in children correlates with disease progression. Pediatrics 1988;82:919-24. 13. Ou C-Y, Kwok S, Mitchell SW, et al. DNA amplification for direct detection of HIV-1 in DNA of peripheral blood mononuclear cells. Science 1988;7:825-35. 14. Amadori A, De Rossi A, Gaguinto C, et al. In vitro production of HIV-specific antibody in children at risk of AIDS. Lancet 1988;1:852-4.
The American Journal of Medicine | 1992
Avi Katz; Alfred J. Fish; Pere Santamaria; Thomas E. Nevins; Youngki Kim; Ralph J. Butkowski
We report three patients, from two unrelated families, with anti-tubular basement membrane (TBM) antibody nephritis associated with membranous nephropathy. This rare disorder is characterized by nephrotic syndrome, tubular dysfunction, and progression to renal failure. Direct immunofluorescent studies in these patients revealed linear IgG deposition along the proximal TBM, while circulating antibodies reacting with proximal TBM but not with glomerular basement membrane were identified by indirect immunofluorescence. Sera from all three patients reacted by enzyme-linked immunosorbent assay and Western immunoblotting with purified 58-kd tubulointerstitial nephritis (TIN) antigen isolated from TBM. Additional reactivity with a 175-kd component, which may be a higher-molecular-weight form of TIN antigen, was observed by immunoblotting. Since recurrent Fanconi syndrome was seen after transplantation in one patient, anti-TBM antibodies were removed by plasmapheresis prior to kidney transplantation in the other two patients. Neither patient has clinical evidence of recurrent anti-TBM nephritis in the allograft despite the posttransplantation reappearance of anti-TBM antibodies in the serum of one patient. Serologic and molecular HLA class I and class II polymorphism analysis has identified the presence of both HLA-B7 and -DRw8 antigens in two unrelated affected individuals (0.3% expected frequency in the white population). We conclude that sera from patients with anti-TBM nephritis associated with membranous nephropathy react with 58-kd TIN antigen previously implicated in the pathogenesis of primary anti-TBM nephritis. This rare autoimmune disorder may be HLA associated with B7 and/or DRw8, providing susceptibility to the disease. Further investigation is needed to understand the pathogenesis of recurrent anti-TBM nephritis in the renal allograft.
Kidney International | 2018
Ankana Daga; Amar J. Majmundar; Daniela A. Braun; Heon Yung Gee; Jennifer A. Lawson; Shirlee Shril; Tilman Jobst-Schwan; Asaf Vivante; David Schapiro; Weizhen Tan; Jillian K. Warejko; Eugen Widmeier; Caleb P. Nelson; Hanan M. Fathy; Zoran Gucev; Neveen A. Soliman; Seema Hashmi; Jan Halbritter; Margarita Halty; Jameela A. Kari; Sherif El-Desoky; Michael A. J. Ferguson; Michael J. Somers; Avram Z. Traum; Deborah Stein; Ghaleb Daouk; Nancy Rodig; Avi Katz; Christian Hanna; Andrew L. Schwaderer
The incidence of nephrolithiasis continues to rise. Previously, we showed that a monogenic cause could be detected in 11.4% of individuals with adult-onset nephrolithiasis or nephrocalcinosis and in 16.7-20.8% of individuals with onset before 18 years of age, using gene panel sequencing of 30 genes known to cause nephrolithiasis/nephrocalcinosis. To overcome the limitations of panel sequencing, we utilized whole exome sequencing in 51 families, who presented before age 25 years with at least one renal stone or with a renal ultrasound finding of nephrocalcinosis to identify the underlying molecular genetic cause of disease. In 15 of 51 families, we detected a monogenic causative mutation by whole exome sequencing. A mutation in seven recessive genes (AGXT, ATP6V1B1, CLDN16, CLDN19, GRHPR, SLC3A1, SLC12A1), in one dominant gene (SLC9A3R1), and in one gene (SLC34A1) with both recessive and dominant inheritance was detected. Seven of the 19 different mutations were not previously described as disease-causing. In one family, a causative mutation in one of 117 genes that may represent phenocopies of nephrolithiasis-causing genes was detected. In nine of 15 families, the genetic diagnosis may have specific implications for stone management and prevention. Several factors that correlated with the higher detection rate in our cohort were younger age at onset of nephrolithiasis/nephrocalcinosis, presence of multiple affected members in a family, and presence of consanguinity. Thus, we established whole exome sequencing as an efficient approach toward a molecular genetic diagnosis in individuals with nephrolithiasis/nephrocalcinosis who manifest before age 25 years.
Connective Tissue Research | 1990
Guo Qui Shen; Ralph J. Butkowski; Tsai Cheng; Jörgen Wieslander; Avi Katz; Janet Cass; Alfred J. Fish
This study examines the similarities and differences in the noncollagenous domain (NC1) of type IV collagen from human glomerular basement membrane (hGBM), alveolar basement membrane (hABM), and placenta (hPBM). Following collagenase digestion, NC1 domain was isolated on Bio-Gel A-0.5m or by cation exchange chromatography on S-Sepharose. NC1 from each source was characterized by SDS PAGE, and two dimension NEPHGE/SDS PAGE. Immunoblotting and ELISA inhibition was performed using antibody probes specific for M28 , M28+, M26 and M24 monomer subunits of human NC1. It was observed that all NC1 subunits were present in hGBM and hABM derived material, however M28 and M28+ monomers were absent in hPBM NC1. These findings indicate that while alpha 1(IV) and alpha 2(IV) collagen chains are present in hGBM, hABM and hPBM, alpha 3(IV) and alpha 4(IV) collagen chains are only found in hGBM and hABM but are absent in hPBM. It can now be appreciated that heterogeneity of alpha (IV) chain composition exists in basement membranes from various organs.
Pediatric Nephrology | 2000
Avi Katz; Glenn H. Bock; Michael Mauer
Abstract Growth failure in children with end-stage renal disease remains a difficult problem. A 2.5-month-old baby in renal failure due to primary hyperoxaluria type I received intensive dialysis aimed at decreasing oxalate tissue accretion. Over 5.5 months, while awaiting transplantation, his growth velocity was 29 cm/year compared with an average 4 cm/year in infants on hemodialysis and 22 cm/year in normal infants of this age. This remarkable growth rate, which could have represented catch-up growth, is hypothesized to be related to the delivered dialysis dose. It is suggested that this relationship be evaluated in a prospective randomized trial.
Pediatric Nephrology | 1993
Avi Katz; Deborah Freese; Christopher J. Danpure; Jonathan I. Scheinman; S. Michael Mauer
We evaluated hepatic alanine glyoxylate aminotransferase (AGT) activity in percutaneous hepatic biopsy material obtained from four children with long-term renal allograft function following transplantation for primary hyperoxaluria type 1 (PH 1). The study was performed to determine whether these successes had occurred because relatively high residual levels of AGT activity had introduced a selection bias. The children ranged from seven months to eight years at transplant and are currently well 7 to 11 years later, with no oxalate deposition on repeated allograft biopsies and creatinine clearances of 80 to 128 ml/min/1.73 m2. AGT activity ranged from 0 to 13.8%, and in two of three patients with detectable levels the AGT was in mitochondria rather than peroxisomes. These results indicate that long-term renal allograft success can occur in spite of severe AGT deficiency. Thus, the therapeutic choice of kidney alone versus combined kidney-liver transplant cannot currently be made by measuring residual hepatic AGT in PH 1. Kidney transplant alone remains a reasonable initial therapeutic alternative for patients with recent onset of renal insufficiency due to PH 1.
Kidney International | 2002
Avi Katz; Maria Luiza Caramori; Susan Sisson-Ross; Thomas J. Groppoli; John M. Basgen; Michael Mauer
Israel Medical Association Journal | 2002
Avi Katz; David J. Van-Dijk; Helena Aingorn; Arie Erman; Malcolm Davies; David Darmon; Hagit Hurvitz; Israel Vlodavsky